The project
Screening and Development of IMPG2-targeted CAR T-Cells for Group 3 Medulloblastoma
This study is developing a new type of CAR T cell therapy that can target hidden cancer signals inside tumor cells, offering a potential treatment for an aggressive form of childhood brain cancer with few options. The goal is to create a highly precise and safe therapy that can better attack tumor cells while sparing healthy tissue.